This website uses cookies to improve the site and user experience. By continuing to browse this site,
you agree to accept our use of cookies. For more information, please review our Cookies Policy
ASTRO 2022 Multidisciplinary Head and Neck Cancers Symposium
Presentations

Tisotumab Vedotin | Head and Neck Squamous Cell Carcinoma | Abstract #15
Efficacy and Safety of Tisotumab Vedotin in Patients With Head and Neck Squamous Cell Carcinoma: Results From a Phase II Cohort